Aequs To Raise ₹650 Cr Via Preferential Issue To Bolster Manufacturing Capacity
- Aequs approved a preferential issue to raise up to ₹650 crore
- The fundraise may support Aequs’ manufacturing capacity; its investors are directly exposed
← Top stories
AEQUS
Aequs Limited · ₹246.05 +1.3% on 25 Sept · 1M −2.2% · 3M +2.7% · 3 stories in 60 days · 1 positive · 0 negative
Open the company tag: stories, tone, the tags it comes with →
Price and news
NSE daily close · markers = sessions where news first tradedPositive newsNegative newsNeutral
Aequs board approves ₹650 cr equity infusion for capacity expansion
- Aequs approved an equity issue of approximately ₹650 crore for capacity expansion
- ₹325 crore is payable upfront upon warrant allotment, or 50% of the issue size
- The capacity expansion may benefit Aequs as it scales manufacturing operations
Aequs promoter group to infuse ₹650 crore through convertible warrants
- Aequs board approved a ₹650 crore preferential issue of warrants to the promoter group
- Aequs shares closed at ₹246, up ₹3.15 or 1.30% on the BSE
- The capital infusion funds Aequs’ business; existing shareholders face potential dilution from warrant conversion